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Sporadic and inflammatory forms of colorectal cancer (CRC) account for more than 80%
of cases. Recent publications have shown mechanistic evidence for the involvement
of gut bacteria in the development of both CRC-forms. Whereas, colon and rectal
cancer have been routinely studied together as CRC, increasing evidence show these
to be distinct diseases. Also, the common use of fecal samples to study microbial
communities may reflect disease state but possibly not the tumor microenvironment.
We performed this study to evaluate differences in bacterial communities found in
tissue samples of 18 rectal-cancer subjects when compared to 18 non-cancer controls.
Samples were collected during exploratory colonoscopy (non-cancer group) or during
surgery for tumor excision (rectal-cancer group). High throughput 16S rRNA amplicon
sequencing of the V4–V5 region was conducted on the Ion PGM platform, reads were
filtered using Qiime and clustered using UPARSE. We observed significant increases in
species richness and diversity in rectal cancer samples, evidenced by the total number
of OTUs and the Shannon and Simpson indexes. Enterotyping analysis divided our
cohort into two groups, with the majority of rectal cancer samples clustering into one
enterotype, characterized by a greater abundance of Bacteroides and Dorea. At the
phylum level, rectal-cancer samples had increased abundance of candidate phylumOD1
(also known as Parcubacteria) whilst non-cancer samples had increased abundance of
Planctomycetes. At the genera level, rectal-cancer samples had higher abundances of
Bacteroides, Phascolarctobacterium, Parabacteroides, Desulfovibrio, and Odoribacter
whereas non-cancer samples had higher abundances of Pseudomonas, Escherichia,
Acinetobacter, Lactobacillus, and Bacillus. Two Bacteroides fragilis OTUs were more
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abundant among rectal-cancer patients seen through 16S rRNA amplicon sequencing,
whose presence was confirmed by immunohistochemistry and enrichment verified by
digital droplet PCR. Our findings point to increased bacterial richness and diversity
in rectal cancer, along with several differences in microbial community composition.
Our work is the first to present evidence for a possible role of bacteria such as
B. fragilis and the phylum Parcubacteria in rectal cancer, emphasizing the need to study
tissue-associated bacteria and specific regions of the gastrointestinal tract in order to
better understand the possible links between the microbiota and rectal cancer.
Keywords: mucosa-associated microbiota, rectal cancer, 16S rRNA gene sequencing, Bacteroides fragilis,
Bacterial diversity and community composition
INTRODUCTION
The gut microbiota is a vast and diverse ensemble of bacteria
and other microorganisms that work together to help digestion,
produce vitamins, fatty acids, amino acids and other bioactive
compounds, and participate in the regulation of our immune,
metabolic, and neurological systems (Shapiro et al., 2014;
Boulangé et al., 2016). The understanding of our microbiota,
together with the determination of its composition when
contrasting healthy vs. diseased states allows the identification of
microorganism disturbances that are possibly related to disease
development and, therefore, offers a new approach for diagnosis
as well as preventive and therapeutic interventions.
Specific dietary components, tobacco and alcohol
consumption, which have been linked to the development
of a number of pathological states (such as obesity, allergy,
diabetes, Crohn’s disease, irritable colon syndrome, and cancer)
are known to drive microbiome alterations and lead to dysbiosis
(Turnbaugh et al., 2009; Leclercq et al., 2014; Allais et al.,
2016). The direct action of these elements or of the dysbiosis
they cause, appears to be instrumental in the pathogenesis of
many diseases and, under certain circumstances, it is possible
that dysbiosis may, per se, have a direct link with disease
development (Duboc et al., 2013). In oncology, studies have
been conducted in different neoplastic conditions, identifying
roles for specific bacteria in carcinogenesis (Kostic et al., 2012;
Riley et al., 2013; Rubinstein et al., 2013), immune evasion
(Gur et al., 2015), modulation of the tumor microenvironment
(Kostic et al., 2013), and interference with anti-cancer immune
responses and immune-surveillance that facilitate chemotherapy
activity (Zitvogel et al., 2013; Galluzzi et al., 2015; Vétizou
et al., 2015). As a consequence, the emerging concept that
cancer needs to be studied considering the complex tumor
microenvironment, which includes components such as tumor
cells, the surrounding microenviroment and the microbiome,
may aid in the development and improvement of cancer
treatment, including immunotherapy (Pitt et al., 2016).
Tumors of the lower digestive tract, which include colon
and rectal cancer, are among the most prevalent neoplasias
worldwide, as well as one of the most fatal. Colorectal cancer
(CRC) is the third most commonly diagnosed cancer with 1.4
million people diagnosed annually (Torre et al., 2015). TheWorld
Health Organization estimates an increase of 77% in the number
of newly diagnosed CRC cases and an increase of 80% in deaths
fromCRC by 2030 (Binefa et al., 2014).Whereas, colon and rectal
cancers have been routinely studied together as CRC, evidences
indicate these to be distinct nosological entities. Differences in
embryological origin, anatomy, treatment, metastatic potential,
and outcome between colon cancer and rectal cancer have led
to discussions as to whether neoplastic lesions of these two
anatomical sites should be considered as different diseases, with
further dichotomization of colon cancers into distal and proximal
(Tamas et al., 2015).
The mechanisms involved in sporadic CRC predisposition
or development are still poorly understood and the long list
of cancer risk factors is continuously expanding and includes
age, tobacco, and alcohol consumption, lack of physical activity,
increased body weight and, most importantly, diet (Moore and
Moore, 1995; Bingham, 2000). Of particular importance is the
fact that all these risk factors can directly or indirectly modify
the microbiota, making the precise definition of their roles a
very complex task. Fecal microbiota studies have contributed
greatly in our understanding of the general gut microbiota
composition and its dysbiosis in different scenarios (Wu et al.,
2013; Sabino et al., 2016). However, possibly due to practical
issues related to obtaining the required biopsy samples—from
patients and controls—there are still very few available studies
focused on the analysis of microbial community compositions
of more specific regions of the lower digestive tract, such as the
proximal and distal colon, and the rectal tissue. Furthermore,
few studies contemplate the fact that fecal- and tissue-associated
microbiota are significantly different (Durbán et al., 2011; Hong
et al., 2011; Mira-Pascual et al., 2015; Flemer et al., 2016). This
fact is particularly relevant for CRC as the intimate crosstalk
between the host’s epithelium layer and the gut microbial
community is a key factor for cell proliferation and development,
as well as the regulation of inflammation, a major driver of
rectal carcinogenesis (Arthur et al., 2014). Such differences lead
to a lack of representativeness with respect to the bacterial
biofilm of the rectal mucosa (Durbán et al., 2011; Gevers et al.,
2014) and may reflect the disease state but possibly not the
tumor microenvironment, which is of great importance to study
possible microbiota:disease links.
Here we have addressed such shortcomings by studying the
tissue-associated microbiota of 36 subjects, 18 with and 18
without rectal adenocarcinoma. The use of 16S rDNA deep
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sequencing allowed us to compare non-cancer x cancer mucosa,
pointing to specific OTUs and bacterial genera potentially
associated with rectal adenocarcinoma.
MATERIALS AND METHODS
Cohort
A total of 36 subjects were included after approval by AC
Camargo Cancer Center’s review board (ACCCC - 1614/11,
January 30th, 2012). Tissue biopsies were collected from subjects
belonging to one of the following groups:
Non-cancer Subjects
(Non-Cancer, NC, n = 18): All subjects had medical indication
of exploratory colonoscopy due to complaints, such as bleeding,
abdominal pain, constipation, and chronic diarrhea. No subjects
had personal or familial history of colorectal cancer or
colitis (either ulcerative, Crohn’s, radiation or infectious colitis,
chronic inflammatory illnesses), previous colonic or small bowel
resection, nor previous colon adenomas or familial polyposis
syndrome. Only individuals with complete colonoscopies that
allowed the full visualization of the entire colon and showed no
significant clinical alterations were included.
Colonoscopy and Biopsy Procedures for the NC
Subjects
All patients received standard instructions for preparation for
colonoscopy that included consumption of 500ml of mannitol
for bowel cleansing, luftal, and bisacodyl. Eligible subjects gave
written informed consent to provide colorectal biopsies, had their
anthropometric measures taken and answered questions about
diet, consumption of alcohol, and tobacco. Colonoscopy was
performed using a Pentax videoscope model FC38LX. During
biopsy procurement, the rectum was inflated with air and care
was taken not to use any suction during advancement of the
scope to 7–8 cm from the anal verge. Sterile biopsy forceps were
not taken out of the channel of the scope until an area that
was completely clear of stool was seen with clear pink mucosa.
Biopsies were taken with 2.2mm sterile standard forceps.
Patients Diagnosed with Rectal Adenocarcinomas
(Rectal-Cancer, RC, n = 18): Tumor specimens, located in
the higher (N = 15), mid (N = 2), and lower rectum
(N = 1), were obtained from surgeries to remove the
tumor mass. All subjects belonging to this group were
recruited at AC Camargo Cancer Center’s Pelvic Surgery
Department, in São Paulo, Brazil. We included patients
that were diagnosed with rectal adenocarcinoma (tumors of
stage pT1 or pT2 low- or mid-straight, pT1 or pT2 or
pT3 high-straight), that had not undergone any neoadjuvant
therapy and had their tumors surgically resected at the
Pelvic Surgery Department, AC Camargo Cancer Center,
with diagnosis confirmed by the Pathology Department of
the same institution. After the histopathologic confirmation
of rectal adenocarcinoma diagnosis, surplus samples were
macrodissected by an experienced pathologist and used for
DNA extraction and bacterial community profiling. Exclusion
criteria were: Patients subjected to neoadjuvant therapy prior
to tissue collection; patients reporting inflammatory bowel
diseases or with hereditary cancer syndromes. We also
excluded all subjects (cases and controls) who reported the
use of antibiotics for at least 4 weeks prior to sample-
collection.
DNA Extraction
DNA extraction started after incubating the samples for
18 h in 600 µl of a lysis buffer (Qiagen) and 15µl of
proteinase K (20µg/µl) at 55◦C. After this period, DNA
samples were extracted using a standard phenol chloroform
protocol, followed by ethanol precipitation, quantification
using a spectrophotometer (Nanodrop—Thermo Scientific), and
visualized on 2% agarose gels to inspect DNA integrity.
PCR Amplification and Sequencing of the
V4–V5 Region of 16S rRNA Gene
Oligonucleotide Primer Selection and Coverage
Analysis
The V4–V5 region was amplified using a primer set designed
to generate amplicons compatible with the chemistry available
for the Ion Torrent PGM platform, that allowed ∼400 nt of
high quality sequences (Ion PGM Sequencing 400 Kit). Coverage
of the primer set was evaluated using the Ribosomal Database
Project’s (RDP—Release 11.2) ProbeMatch (Cole et al., 2014) and
the ARB Silva’s (Release 115) TestPrime (Klindworth et al., 2013).
The forward primer (5′-AYTGGGYDTAAAGNG-3′) and reverse
primer (5′-CCGTCAATTCNTTTRAGTTT-3′) corresponded to
positions 562 and 906, respectively, of the Escherichia coli 16S
rRNA gene.
PCR Amplification and Amplicon Sequencing
Three 50 µl amplification replicate reactions were performed
per sample, each containing: 2.5 µM of each primer; 25 µl of
Kapa Hotstart High Fidelity Master Mix (Kapa Technologies)
and 25 ng of genomic DNA (gDNA). Thermocycling conditions
were: 95◦C, 3min; 98◦C, 15 s, and 40◦C, 30 s for 35 cycles;
followed by a last extension step at 72◦C for 5 min. Amplicons
of the three reactions from each subject were pooled and
purified using a MinElute PCR Purification Kit (Qiagen). The
purified products were run on 1.5% agarose gels and gel
bands within the expected amplicon range were excised using
sterile and disposable scalpels and purified using the Qiaquick
gel extraction kit (Qiagen) to remove artifacts, primer-dimers
and non-specific bands. Amplicons were end-repaired and
Ion Torrent adaptors with barcodes were ligated. Equimolar
amounts of amplicons from each sample were pooled, using
the Ion Torrent qPCR quantitation kit (Thermo Scientific,
Carlsbad, USA), and used for emulsion PCR. All samples were
sequenced on the Ion torrent PGM platform (Thermo Scientific,
Carlsbad, USA) using two 318 v2 chips. Samples from both
groups were processed simultaneously, to avoid possible batch
effects.
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Sequence Analysis
Sequence Filtering
Sequences processed by the latest version of the Ion Torrent
server (v3.6.2) were used as input into the Qiime (Quantitative
insights into microbial ecology) software package (Version 1.6.0)
(Caporaso et al., 2010a). We first removed sequences with an
average quality score <20 using a 50 nt sliding window. Then,
we identified barcodes used for subject-assignment, allowing a
maximum of 2 mismatches, and discarded sequences with no
barcodes, and <200 nt or >500 nt after barcode removal. PCR
primers identified at the start or at the end of the reads, allowing a
maximum of 4 nt mismatches, were trimmed and sequences with
no identifiable primers were discarded. After primer trimming
we removed all sequences below 200 nt and the remaining
sequences were used as input for downstream analysis.
Sequence Clustering and OTU Filtering
Filtered sequences were clustered with 97% identity using
UPARSE (implemented in USEARCH v7) (Edgar, 2013)
and the seed sequence of each cluster was picked as a
representative. Chimeric sequences (and clusters) were identified
using UCHIME (Edgar et al., 2011) and the Broad Institute’s
chimera slayer database (version microbiomeutil-r20110519)
and excluded from further analysis. The RDP classifier (Wang
et al., 2007), as implemented within the Qiime interface (default
parameters), was used to assign taxonomic ranks using a
minimum confidence value of 80% and, subsequently, to each
operational taxonomic unit (OTU). Unless otherwise stated,
OTUs that occurred in less than 25% of all samples and with less
than 3 reads were not considered.
Alpha and Beta Diversity Analysis
We rarefied the OTU table to 17,414 sequences per sample in
order to calculate species diversity, using the Shannon-Weaver
index (Shannon, 1948) and the Simpson index (Simpson, 1949),
and richness (by using the observed species) implemented in the
R Phyloseq package (McMurdie and Holmes, 2013).
For beta diversity analysis, OTU-representative sequences
were aligned using PyNAST (Caporaso et al., 2010b) against the
aligned green genes core set (DeSantis et al., 2006) with Qiime
default parameters, and the alignments were lanemask-filtered
(Lane, 1991). A phylogenetic tree was built using FastTree (Price
et al., 2009), weighted and unweighted UniFrac (Lozupone and
Knight, 2005) distances were calculated and a distancematrix was
generated. Using the R phyloseq package, distance matrices were
used to calculate coordinates for principal coordinate analysis
(PCoA).
Enterotypes
Community types of each sample were analyzed by the Dirichlet
multinomial mixture model-based method (Holmes et al., 2012)
using rarefied genera level counts of 16S rRNA sequencing
reads. Partioning around medoids (PAM) enterotyping was
performed in R using genera level relative abundances and the
“cluster” package (Maechler et al., 2015). We applied 4 distance
metrics: Weighted UniFrac, Unweighted UniFrac, root Jensen-
Shannon divergence, and Bray-Curtis and assessed the quality of
the clusters using prediction strength (Tibshirani and Walther,
2005), silhouette index (Rousseeuw, 1987), and the Calin´ski-
Harabasz statistic (Calinski and Harabasz, 1974) using the “fpc”
R package (Hennig, 2015).
Differential Abundance Analysis
To investigate differences in OTU, phyla and genera abundances
between both groups, raw counts were normalized then
log transformed using the normalization method below, as
performed by a previous study (Sanapareddy et al., 2012):
Normalized count = log10((
raw count
number of sequences in that sample
)
× average number of sequences per sample+1)
We also evaluated high-level phenotypical differences in
microbial composition between both groups. Quality control
passed sequences were closed-reference picked at 97% identity
using UCLUST_Ref (Edgar, 2010) and the green genes core
set (Version 13.5). The resulting OTU table was rarefied to
13,944 sequences and submitted to BugBase (http://github.com/
danknights/bugbase) in order to calculate differences between
both groups in terms of microbial phenotypes.
Data Validation
Digital Droplet PCR of Bacteroides Fragilis 16S rRNA
We detected and quantified the absolute number of 16S
rRNA B. fragilis copies in our samples using the QX200TM
Droplet DigitalTM PCR System (Bio-Rad). The primers
used to amplify the B. fragilis 16S rRNA gene were:
BF-fwd 5′-TCRGGAAGAAAGCTTGCT-3′ and BF-rev 5′-
CATCCTTTACCGGAATCCT-3′(Tong et al., 2011) and to
ensure further specificity, a labeled probe BF-p 5′(FAM)-
ACACGTATCCAACCTGCCCTTTACTCG-3′ (BHQ1)
(Tong et al., 2011) was included in the reaction. We used a
commercial RNAseP Copy Number Reference Assay (Thermo-
Fisher) to detect and quantify human DNA. Microdroplets
(≈20.000/reaction) were generated on the Bio-Rad QX-100
following the manufacturer’s instructions. RNAse P and
B. fragilis ddPCR were performed in 96 well-plates, in a final
volume of 20 µl, containing: 15 ng of total DNA, 10 ul of ddPCR
supermix for probes (Bio-Rad), 8 pmol of each PCR BF-primer
and 2 pmol of the BF-probe, or 1 µl of RNAse P assay. PCR
conditions were: 50◦C- 2 min; 95◦C- 10 min; 95◦C- 15 s and
60◦C- 1 min for 40 cycles. After cycling, the 96-well plate was
immediately transferred on a QX200 Droplet Reader (Bio-Rad),
where flow cytometric analysis determined the fraction of
PCR-positive droplets vs. the number of PCR-negative droplets
in the original sample. Data acquisition and quantification was
carried out using QuantaSoft Software (Bio-Rad). To ensure
the accuracy of the results, a minimum of 10,000 acceptable
droplets per reaction were required for quantification using
the QuantaSoft software. Samples yielding a minimum of 3
positive droplets from 10–15,000 droplets analyzed were scored
as positive.
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Immunohistochemistry
Immunohistochemistry was performed in an automated
Benchmark platform (Ventana Medical Systems, USA) for
Anti-B. fragilis LPS antibody (mouse monoclonal—Abcam
1265/30) in whole slide tissues. Alkaline phosphatase conjugated
to secondary polymeric system was used for IHC visualization.
The selection of positive and negative samples was guided by the
high-throughput sequencing (HTS) data and used to confirm the
presence of B. fragilis in the sample set. The primary antibody
was omitted to evaluate background staining.
Statistical Analysis
Wilcoxon tests were used to compare mean differences between
tumor and biopsy samples for phyla, genera and OTU log-
abundances. Considering t= total number of taxa tested, p= raw
p-value and R= sorted rank of the taxon, P-values were corrected
for multiple testing (Sanapareddy et al., 2012) using:
Adjusted p value =
t × p
R
Fold changes for each genera/OTU were calculated using:
Log2 FC = log2(RC average + 1) − log2(NC average + 1)
Chi-Square tests were performed on subject’s categorical data
such as gender, alcohol and tobacco use and vital status.
Student t-tests were performed to compare differences in the
means between both groups for age, height, weight, BMI, and
alpha diversity. We used ANOSIM and ADONIS (Oksanen
et al., 2016) to compare differences in beta-diversity between
groups using 3 distance metrics weighted UniFrac, unweighted
UniFrac and Bray-Curtis for categorical, and numerical variables,
respectively. Linear models were built using normalized counts at
the genera andOTU level to investigate associations with clinical-
pathological characteristics of rectal-cancer samples, such as
lymph node and perineural neoplastic invasion status. Unless
otherwise stated, values were reported as mean ± SD (standard
deviation) and P-values <0.05 were considered statistically
significant. All calculations were performed within the R
statistical computing environment (R Foundation, 2011) unless
otherwise stated.
RESULTS
Subjects and Tissue Sample
Characteristics
We analyzed tissue-associated bacteria from mucosal biopsies of
18 non-cancer controls and 18 rectal adenocarcinoma tumors
using 16S rRNA high throughput amplicon sequencing. We
found no significant differences between rectal-cancer and non-
cancer subjects regarding age and gender distribution, tobacco,
and alcohol use and other risk factors (Table 1). All samples
consisted of rectal-biopsies. The biopsies of individuals with no
tumor lesions derived from the mid rectum and were distributed
along the ∼12 cm-long human rectum, with most samples
deriving from the higher-mid rectum (94%).
TABLE 1 | Subject and sample data.
Demographic Non-cancer Rectal-cancer P-value
(n = 18) (n = 18)
Age 55.2 ± 15.7 59.3 ± 8.8 0.348
GENDER (%)
Female 9 (50) 8 (44) 1
Male 9 (50) 10 (56)
Height 1.65 ± 0.08 1.70 ± 0.09 0.1
Weight 73 ± 14.1 73.8 ± 13.5 0.87
BMI 26.6 ± 3.7 25.3 ± 3.6 0.29
ALCOHOL USE (%)
Yes 8 (44) 5 (28) 0.568
No 10 (56) 12 (67)
Undetermined 0 (0) 1 (5)
TOBACCO USE (%)
Yes 12 (67) 6 (28) 0.129
No 6 (33) 11 (62)
Undetermined 0 (0) 1 (5)
Pathological tumor size staging (%)
pT2 N.A. 5 (28) N.A.
pT3 13 (72)
Pathological lymph node metastasis staging (%)
pN0 N.A. 11 (62) N.A.
pN1 3 (16)
pN2 4 (22)
Distant metastasis staging (%)
M0 N.A. 18 (100) N.A.
Invasion (%)
Perineural N.A. 4 (22) N.A.
Angiolymphatic 14 (78)
Vital status (%)
Alive 18 (100) 17 (95) 1
Deceased 0 (0) 1 (5)
N.A., Not applicable.
Primer Coverage
Our analyses indicate that the PCR primers used here (V4–V5
region of the 16S rRNA gene) cover 84.4 and 52.1% of all
eubacterial sequences present in the ARB SILVA database and
the Ribosomal Database Project, respectively (Supplementary
Table 1). Coverage rates were evenly distributed among most
bacterial phyla, except for Verrucomicrobia, where coverage rates
were 21 and 10.9%, dropping below the 75 and 48% averages of
taxa present in the SILVA and RDP databases, respectively.
Sequence Analysis
Sequence Generation and Filtering
A total of 12,078,140 sequence reads were generated, with
a mean sequence length of 304.5 ± 97.34 nt (standard
deviation—std). After quality filtering and primer trimming,
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5,593,020 (46.3%) sequences remained, with an average of
155,361 sequences/sample and a mean sequence length of
315± 30 nt.
Sequence Clustering and OTU Filtering
When all individuals were considered, a total of 3222 OTUs were
obtained. Thirty-one (0.7%) OTUs were identified as chimeras by
UCHIME and 209 (4.7%) could not be assigned to a taxonomic
rank. After filtering OTUs with less than three sequences and not
present in at least 25% of all samples (NC and RC combined),
1492 OTUs remained.
Alpha and Beta Diversity
Species Richness and Diversity
We observed significantly higher species richness and
species diversity in rectal cancer samples compared to
controls. This was observed for the number of OTUs, the
Shannon index and the Simpson Index (P-values = 0.002,
<0.001, and <0.001, respectively) (Figures 1A,B). When
we stratified rectal-cancer samples into smaller (pT2) and
larger tumors (pT3), we observed an increase in species
richness, with an average of 280 and 366 OTUs, respectively,
compared to 236 OTUs in NC; however this effect reached
no statistical significance between pT2 and pT3, maybe
because of the reduced number of pT2 samples (N = 5,
compared to N = 13 for pT3) (Figure 1B and data not
shown).
Beta Diversity
Using three distance metrics we observed consistent and
statistically significant differences between the sample groups
when considering cancer status (Bray-Curtis, Unweighted
and Weighted UniFrac; p-value: 0.001; ANOSIM using 999
permutations), but not for any other categorical or numerical
variable, which included amplicon library construction,
age, gender, BMI, alcohol, and tobacco use (Figure 1D;
Supplementary Table 2).
Enterotypes
Enterotyping analysis using a Dirichlet multinomial mixture
model divided our cohort in two clusters (Figures 2A–C).
Enterotype I was significantly enriched for rectal-cancer samples,
whilst enterotype II was composed mostly of non-cancer
samples (p-value: 0.0001, Fisher’s exact test). Enterotype I
had higher abundances of Bacteroides, Clostridiales, Dorea,
and other genera, whilst enterotype II was characterized
by elevated amounts of Pseudomonas and Brevundimonas
(Figure 2D). When using the PAM based enterotyping
method and criterion adopted by a meta-analysis of human
enterotypes (Koren et al., 2013), we found two enterotypes
with prediction strength above 0.9 (meaning that 90% of
the data points fall within the cluster and 10% are outliers)
using the Weighted UniFrac distance (Supplementary
Figure 1).
Global Signatures of the Microbial
Community
Phyla Log Abundances
We observed a significant difference in the log abundances of 6
out of 12 detected phyla between both groups (Supplementary
Figure 2). The most abundant phyla identified were (in
decreasing order) Proteobacteria, Firmicutes, Bacteroidetes,
Fusobacteria, Actinobacteria, and Verrucomicrobia. In
non-cancer samples, we observed higher log abundances
of Actinobacteria, Cyanobacteria, Proteobacteria, and
Planctomycetes, whose presence was detected in 9/18 NC
samples, with an average log abundance of 0.54 and was absent
from all RC individuals (p-value < 0.001). In rectal-cancer
we found greater log abundances of Bacteroidetes and of the
much less known candidate phylum OD1 (also known as
Parcubacteria), whose presence was detected in 14/18 RC
samples with an average log abundance of 0.71 vs. 1/19 NC
samples and an average log abundance of 0.02 (p-value < 0.001).
Genera Log Abundances
At the genus level, 86 out of 260 genera (33%) showed
significant differential log abundances between both groups
(Figure 3A and Supplementary Table 3). The top five genera with
differential log abundances between the groups were Bacteroides,
Phascolarctobacterium,Odoribacter, Parabacteroides, Desulfobrio
(more abundant in the cancer group), and Lactobacillus,
Pseudomonas, Bacillus, Escherichia, Acinetobacter (more
abundant in the non-cancer set) (Figure 3B).
OTU Log Abundances
Of the 1492 OTUs identified, 163 (10.9%) were found to
have significant differential log abundances between both
groups (Figure 3C). Three OTUs assigned to the genus
Bacteroides, two belonging to B. fragilis and one to B.
uniformis, as well as OTUs assigned to Bilophila sp. and
Fusobacterium sp., were significantly more abundant in rectal-
cancer samples (Figure 3D). In non-cancer samples, OTUs
assigned to Alcaligenes faecalis, Bacillus cereus, Lactobacillus
delbruecki, Prevotella melaninogenica and Pseudomonas
ssp had higher log abundances compared to rectal-cancer
samples. Four OTUs belonging to the Bacilli class were more
abundant among non-cancer samples, including L. delbrueckii
(Figure 3D).
When analyzing high-level phenotypical differences, the most
striking differences included a higher abundance of anaerobic
bacteria and a deficit in biofilm-forming bacteria in rectal-
cancer samples (Supplementary Figure 3). In our searches for
associations between rectal-cancer samples’ clinical data and
genera/OTU log abundances using linear regression, we found
significant associations between genera/OTUs with regards to
the presence of lymph node disease (Supplementary Table 4) and
perineural invasion (data not shown). We found a significant
increase of Coprococcus, Dorea, Roseburia, and Mogibacterium
in lymph node positive rectal-cancer (Supplementary
Figure 4).
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FIGURE 1 | Alpha and beta diversity for non-cancer and rectal-cancer samples. (A) Rarefaction curves showing the average number of observed OTUs for
both groups. Error bars represent ± standard error of the mean. Blue: Non-cancer samples; red: Rectal-cancer samples. (B) Rarefaction curves showing the average
number of observed OTUs for NC samples and for smaller (pT2) and larger rectal tumors (pT3). Error bars represent ± standard error of the mean. (C) Boxplots
showing alpha diversity in rectal-cancer samples and non-cancer samples using different metrics (Observed OTUs, Shannon index and Simpson index). (D) Principal
Coordinate Analysis (PCoA) ordination plots for four distance metrics (Bray-Curtis, Jensen-Shannon Divergence, Weighted and Unweighted UniFrac). Ellipses
represent the 95% confidence level assuming a multivariate t-distribution.
ddPCR Confirms the Higher Counts of
B. fragilis in Tumor Samples
As two OTUs classified as B. fragilis were among the smallest
p-values found and with the highest fold change between the
groups, we designed a specific ddPCR assay for B. fragilis in
order to verify the validity of the results using an alternative
approach. As can be seen in Figures 4A,B, we observed the
expected correlation (R2 = 0.78) between both methods and
confirmed the higher ratio of B. fragilis/human DNA in rectal
cancer samples, validating the results of our sequencing approach
(P-value = 0.04, Wilcoxon Rank-Sum Test). To further evidence
the presence of B. fragilis in tumor specimens, we performed an
immunohistochemistry assay on 3 rectal-cancer samples using an
anti-B. fragilis LPS antibody and found that this bacterium was
present in rectal-cancer tissue (Figures 4C,D).
DISCUSSION
In face of the microbiota gradient found in the human digestive
tract (Zhang et al., 2014; Gao et al., 2015; Flemer et al., 2016)
and the possibility that tissue-associated microorganisms could
play a more direct role in immunomodulation and cancer
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 7 December 2016 | Volume 6 | Article 179
Thomas et al. Tissue-Associated Bacteria in Rectal Cancer
FIGURE 2 | Enterotyping analysis reveals the presence of two community types. (A) Fitting to the Dirichlet Multinomial Mixture model indicates optimal
classification into two community types. (B) Distribution of rectal-cancer samples and non-cancer samples in both enterotypes (P = 0.0001, Fisher’s exact test). (C)
Non-metric dimensional scaling (NMDS) ordination plot of Jensen–Shannon divergence values between samples. Red, community type-1; green, community type-2.
(D) Relative abundances of the top 8 most abundant genera in the two community types.
development, we investigated bacterial populations present in
tissue biopsies, which may be relevant to pathological processes.
Instead of studying colon and rectum samples together, our
work is more specific as it is focused and contains only
rectal tumors. Whereas, we achieved high 16S rRNA coverage
from a large spectrum of bacteria from cancer samples, before
any therapeutic intervention, we also see limitations, such as
our relatively small sample size of 36 individuals. However,
effect size analysis (Kelly et al., 2015) between both groups
revealed an ω2 ranging from 0.13 to 0.26, depending on the
metric of pairwise distance, with PERMANOVA p-values <0.001
and power of 1 (data not shown), a finding that indicates
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FIGURE 3 | Genera and OTU level differential abundance signatures. (A) Volcano plot for all 260 genera found in our samples. Red points indicate genera with
an adjusted p-value <0.05; green points indicate genera with an adjusted p-value <0.05 and log2FC > 1. Points circled in black are genera shown in the adjacent
boxplot. (B) Boxplots showing log abundances for 5 genera with significant increases (top) and 5 genera with significant decreases in rectal-cancer samples (bottom).
(C) Volcano plot for 1492 OTUs found in our samples. Points color scheme is the same as in (A). (D) Boxplots showing log abundances for 5 OTUs with significant
increases (top) and 5 OTUs with significant decreases in rectal-cancer samples (bottom).
that this sample size allows the observation of significant
microbial differences between our two sample groups. We also
need to point out that, whereas the primer pair used here
gives a good coverage of most phyla, it has a poor coverage
of the two closely related bacteria phyla Lentisphaerae and
Verrucomicrobia.
In our study, we observed increased species-diversity
and -richness among rectal-cancer samples. Higher species-
diversity and -richness were seen in rectal tissue samples
from adenomas compared to normal samples (Sanapareddy
et al., 2012) and CRCs vs. adenomas (Nakatsu et al., 2015)
and increased richness was found in CRCs compared to
both adenomas and controls (Mira-Pascual et al., 2015).
However, when looking at fecal samples, studies have had
conflicting results. One study found increased diversity of
both genes and genera along the adenoma-carcinoma transition
(Feng et al., 2015), whereas another found a decrease in
diversity when comparing carcinoma samples and normal
controls (Ahn et al., 2013) and a third found no differences
between controls, adenomas and carcinomas (Zeller et al.,
2014). It is noteworthy to state that these fecal studies
grouped proximal and distal colon cancers together with rectal
cancers, which could have led to differences in their results.
We should note that the five cases of early-stage lesions
(pT2) showed, on average, intermediate microbial richness,
when compared to non-cancer biopsies and a more advanced
neoplastic stage (pT3). This suggests that increased species
richness of cancer lesions could have an early role in rectal
carcinogenesis.
Inter-individual microbial community heterogeneity
of the human gut is influenced by spatial distribution,
micro-heterogeneity, host genetics, dietary preferences,
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FIGURE 4 | Alternative approaches demonstrating the presence of B. fragilis. (A) B. fragilis ddPCR quantification correlates with HTS-derived data. Using
linear regression we obtained a correlation of R2 = 0.78, P < 0.001. Blue: Non-cancer samples; red: Rectal-cancer samples. (B) Boxplot showing log10 of the
ddPCR ratio found for B. fragilis after normalizing for RNAseP values for both groups. Blue: Non-cancer samples; red: Rectal-cancer samples. (C,D)
Immunohistochemisty analysis of two B. fragilis-positive rectal-cancer samples, demonstrating the presence of this microbe (antibodies are labeled in red and shown
with arrows) using magnification of 1000X.
and mucin content (Eckburg et al., 2005; Hong et al.,
2011; Zhang et al., 2014), and has posed a long-
standing challenge when investigating microbial signatures
implicated in CRC tumorigenesis. However, our results
show that despite the high inter-individual differences,
a common microbial community pattern appears to
emerge, as shown in the PCoA analysis that clustered non-
cancer and rectal-cancer groups separately (Figure 1D),
suggesting a common dysbiotic setting related to this
neoplasia.
We performed a global analysis of high-level phenotypical
differences for bacteria identified in both groups. We highlight
the higher abundance of anaerobic bacteria in the RC group
in agreement with a previous study (Warren et al., 2013)
and the reduction of biofilm-forming bacteria. The latter is a
finding that may point to barrier breakage that would contribute
to rectal colonization by relevant bacteria (Reid et al., 2001)
(Supplementary Figure 3).
The alterations we found at the phylum level include
higher levels of Cyanobacteria (possibly Melainabacteria) (Soo
et al., 2014), Actinobacteria, Bacteroidetes, OD1, Proteobacteria,
and Planctomycetes in the RC-group. We should note an
important abundance difference for bacteria of the candidate
phylum OD1 (Parcubacteria). These highly adapted organisms
have not been isolated in vitro yet; they have small genomes
(<1Mb) and reduced metabolic properties identified in a
range of anoxic environments. The absence of biosynthetic
capabilities and DNA repair enzymes, derived from the
genomic analyses of some OD1 bacteria, suggests a role
as ectosymbionts (Nelson and Stegen, 2015). However, the
putative role of these microbes in rectal cancer remains
to be determined. A second phylum, Planctomycetes, which
are atypical bacteria (Fuerst and Sagulenko, 2011) relatively
close to Verrucomicrobia (Hou et al., 2008) and more
frequently observed in aquatic environments (such as saltwater,
fresh water, and acidic mud), also showed potential as a
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 10 December 2016 | Volume 6 | Article 179
Thomas et al. Tissue-Associated Bacteria in Rectal Cancer
biomarker for RC, with striking differences between the
groups.
Interestingly, our study also indicated the differential
abundance of more specific microbes after comparing NC and
RC groups. B. fragilis, a symbiotic organism common to the
human intestinal tract, was found to be more abundant in rectal-
cancer samples seen by 16S rRNAHTS and confirmed by ddPCR.
Other studies that investigated tissue-associated bacteria also
found increased abundance of B. fragilis in tumor samples (Wang
et al., 2012; Zeller et al., 2014; Nakatsu et al., 2015). B. fragilis
has been identified as an important human intestinal symbiont
and has been suggested to act as a “keystone pathogen” in the
development of CRC (Hajishengallis et al., 2012). B. fragilis is
an obligate anaerobe and is a minority member of the normal
colonic microbiota with a propensity for mucosal adherence
(Sears et al., 2014). Previous reports have linked enterotoxigenic
B. fragilis (ETBF) to human diarrheal illnesses and increased
tumorigenesis in an IL-23-dependent and STAT3-dependent
manner (Wick et al., 2014). The toxin fragylisin, produced by
ETBF, is a zinc-dependent metalloprotease that triggers NF-kB
signaling and cleaves E-cadherin, and has been suggested to be
oncogenic (Wu et al., 2009). Bacterial genera known for their
role in butyrate production, such as Ruminococcus, Roseburia,
and Butyricimonas were more abundant among rectal-cancers,
differing from results reported so far. An explanation for this
difference could involve the fact that most data has been derived
from fecal samples and/or grouping different anatomical tumor
sites (such as proximal, distal, and rectal). An OTU assigned
to Bilophila, a bile-resistant, strictly anaerobic bacterial genus,
was also more abundant among rectal-cancer samples, and
evidence suggests that products of bacterial bile acid conjugation,
secondary bile acids, are carcinogenic (McGarr et al., 2005;
Ridlon et al., 2014). Desulfovibrio, a commensal sulfate-reducing
bacterium, may contribute to mucosal inflammation through
hydrogen sulfide production, a resulting by-product of sulfated
mucin metabolism (Earley et al., 2015). Phascolarctobacterium,
known to produce propionate via succinate fermentation, was
also increased among cancer samples. On the other hand, we
found that L. delbrueckii was more abundant in non-cancer
samples. Probiotic Lactobacilli can modify the enteric flora and
are thought to have a beneficial effect on enterocolitis. Treatment
of IL-10-deficient mice with the probiotic Lactobacillus salivarius
ssp. reduced the intensity of mucosal inflammation and the
incidence of colon cancer from 50 to 10%. These effects
were accompanied by significant reductions in fecal coliform,
enterococci, and Clostridium perfringens levels (O’Mahony et al.,
2001). This study exemplifies the effect of changes at the flora
level on the development of inflammation, and supports the
hypothesis that there are “protective” species and “harmful”
species in the normal bacterial flora.
After identifying relevant cancer-related microorganisms, the
next steps of microbiome studies will certainly involve microbial
manipulations to reduce disease-associated agents, or increase
the frequency of protective and health-associated microbes. This
can be achieved through diet, exemplified by a previous study
using animal models that showed taurine consumption lead to
a reduction of Proteobacteria (especially Helicobacter), as well as
an elevation in short-chain fatty acids (SCFA) and a reduction
in fecal lipopolysaccharides (LPS) (Yu et al., 2016). Duque et al.,
recently demonstrated, using SHIME R© (Simulator of the Human
Microbial Ecosystem), that the consumption of non-pasteurized
fresh orange juice was able to significantly increase levels of
Lactobacillus spp., Enterococcus spp., Bifidobacterium spp., and
Clostridium spp. and to reduce enterobacteria (Duque et al.,
2016).
Long before associations between cancer and the microbial
flora started to be uncovered, diet recommendations—including
low consumption of red meat and fat, and high ingestion of
fibers and vegetables—have been recognized as protective against
the development of colorectal cancer. Current evidences suggest
that diet recommendations may be effective, together with tissue
environment and host-related factors, because they also help
shape the gut microbiota (Sonnenburg and Bäckhed, 2016).
Further research may show that treatment of rectal dysbiosis
may contribute to the prevention of inflammation-induced rectal
carcinoma development and aid in chemotherapy and overall
treatment response (Yang and Pei, 2006).
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